Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy
European Journal of Immunology · 2024
DOI: 10.1002/eji.202451149 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Stefanie Dietz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Tuebingen University Children's Hospital, Tuebingen, Germany. Hauptthemen laut MEDLINE: Receptor, Adenosine A2B, Myeloid Cells, Mice, Knockout. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jürgen Manchot Stiftung, NIDDK NIH HHS, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
During pregnancy, the maternal immune system must carefully balance protection against pathogens with tolerance toward the semiallogeneic fetus. Dysfunctions of the immune system can lead to severe complications such as preeclampsia, fetal growth restriction, or pregnancy loss. Adenosine plays a role in physiological processes and plasma‐level increase during pregnancy. The adenosine receptor A2B (A2BR), which is expressed on both, immune and nonimmune cells, is activated by high adenosine concentrations, achieved during pregnancy. We investigated the impact of A2BR expressed on myeloid cells on immune regulation during pregnancy using a mouse model with myeloid deficiency for A2BR. We demonstrate systemic changes in myeloid and lymphoid cell populations during pregnancy in A2BR‐KO (Adora2B923 f/f ‐LysM Cre ) mice with increased monocytes, neutrophils, and T cells but decreased B cells as well as altered T‐cell subpopulations with decreased Th1 cells and Tregs and increased Th17 cells. Lack of A2BR on myeloid cells caused an increased systemic expression of IL‐6 but decreased systemic accumulation and function of MDSC and reduced numbers of uterine natural killer cells. The pregnancy outcome was only marginally affected. Our results demonstrate that A2BR on myeloid cells plays a role in immune regulation during pregnancy, but the clinical impact on pregnancy remains unclear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Tuebingen University Children's Hospital, Tuebingen, Germany.
- Department of Neonatology, Heidelberg University, Medical Faculty, Heidelberg, Germany.
- Health Science Center Houston, University of Texas, Houston, Texas, USA.
ORCID-Profile: Trim Lajqi, Natascha Köstlin-Gille
Förderung
- Jürgen Manchot Stiftung
- NIDDK NIH HHS
- Deutsche Forschungsgemeinschaft
- NHLBI NIH HHS
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
Zitieren
APA
Dietz, S., Hebel, J., Rühle, J., Huff, A., Eltzschig, H. K., Lajqi, T., Poets, C. F., Gille, C., & Köstlin-Gille, N. (2024). Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy. European Journal of Immunology. https://doi.org/10.1002/eji.202451149
Vancouver
Dietz S, Hebel J, Rühle J, Huff A, Eltzschig HK, Lajqi T, et al. Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy. European Journal of Immunology. 2024. doi:10.1002/eji.202451149
BibTeX
@article{Dietz2024,
author = {Dietz, Stefanie and Hebel, Janine and Rühle, Jessica and Huff, Alisha and Eltzschig, Holger K and Lajqi, Trim and Poets, Christian F and Gille, Christian and Köstlin-Gille, Natascha},
title = {Impact of the adenosine receptor A2BR expressed on myeloid cells on immune regulation during pregnancy},
journal = {European Journal of Immunology},
year = {2024},
doi = {10.1002/eji.202451149}
}
EUVIMED